These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12690626

  • 1. A highly sensitive detection method for somatic mutations in p53 gene.
    Sato T, Sato A, Ishihara H, Konishi K.
    Rinsho Byori; 2003 Feb; 51(2):98-106. PubMed ID: 12690626
    [Abstract] [Full Text] [Related]

  • 2. Surveyor nuclease-based detection of p53 gene mutations in haematological malignancy.
    Mitani N, Niwa Y, Okamoto Y.
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):557-9. PubMed ID: 17961311
    [Abstract] [Full Text] [Related]

  • 3. The IARC TP53 database: new online mutation analysis and recommendations to users.
    Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P.
    Hum Mutat; 2002 Jun; 19(6):607-14. PubMed ID: 12007217
    [Abstract] [Full Text] [Related]

  • 4. Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene.
    Tõnisson N, Zernant J, Kurg A, Pavel H, Slavin G, Roomere H, Meiel A, Hainaut P, Metspalu A.
    Proc Natl Acad Sci U S A; 2002 Apr 16; 99(8):5503-8. PubMed ID: 11960007
    [Abstract] [Full Text] [Related]

  • 5. Rapid identification of single nucleotide polymorphisms by fluorescence-based capillary electrophoresis.
    Bernat M, Titos E, Clària J.
    Genet Mol Res; 2002 Mar 31; 1(1):72-8. PubMed ID: 14963815
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the amplification refractory mutation allele-specific polymerase chain reaction system for sensitive and specific detection of p53 mutations in DNA.
    Low EO, Jones AM, Gibbins JR, Walker DM.
    J Pathol; 2000 Mar 31; 190(4):512-5. PubMed ID: 10700003
    [Abstract] [Full Text] [Related]

  • 7. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
    Tessitore A, Di Rocco ZC, Cannita K, Ricevuto E, Toniato E, Tosi M, Ficorella C, Frati L, Gulino A, Marchetti P, Martinotti S.
    Genes Chromosomes Cancer; 2002 Sep 31; 35(1):86-91. PubMed ID: 12203794
    [Abstract] [Full Text] [Related]

  • 8. A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine.
    van Oers JM, Lurkin I, van Exsel AJ, Nijsen Y, van Rhijn BW, van der Aa MN, Zwarthoff EC.
    Clin Cancer Res; 2005 Nov 01; 11(21):7743-8. PubMed ID: 16278395
    [Abstract] [Full Text] [Related]

  • 9. p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer.
    Phillips HA, Howard GC, Miller WR.
    Br J Cancer; 2000 Jan 01; 82(1):136-41. PubMed ID: 10638980
    [Abstract] [Full Text] [Related]

  • 10. p53 mutations in urinary bladder cancer.
    Berggren P, Steineck G, Adolfsson J, Hansson J, Jansson O, Larsson P, Sandstedt B, Wijkström H, Hemminki K.
    Br J Cancer; 2001 Jun 01; 84(11):1505-11. PubMed ID: 11384101
    [Abstract] [Full Text] [Related]

  • 11. Thirtyfold multiplex genotyping of the p53 gene using solid phase capturable dideoxynucleotides and mass spectrometry.
    Kim S, Ulz ME, Nguyen T, Li CM, Sato T, Tycko B, Ju J.
    Genomics; 2004 May 01; 83(5):924-31. PubMed ID: 15081121
    [Abstract] [Full Text] [Related]

  • 12. Detection of hotspot mutations and polymorphisms using an enhanced PCR-RFLP approach.
    Liu WH, Kaur M, Makrigiorgos GM.
    Hum Mutat; 2003 May 01; 21(5):535-41. PubMed ID: 12673796
    [Abstract] [Full Text] [Related]

  • 13. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
    Besaratinia A, Bates SE, Pfeifer GP.
    Cancer Res; 2002 Aug 01; 62(15):4331-8. PubMed ID: 12154037
    [Abstract] [Full Text] [Related]

  • 14. [Application of oligonucleotide microarray primer extension to detection of p53 single nucleotide polymorphisms].
    Wu QH, Ma WL, Zhang B, Guo QY, Li L, Zheng WL.
    Ai Zheng; 2005 Jul 01; 24(7):898-902. PubMed ID: 16004824
    [Abstract] [Full Text] [Related]

  • 15. Highly selective isolation of unknown mutations in diverse DNA fragments: toward new multiplex screening in cancer.
    Chakrabarti S, Price BD, Tetradis S, Fox EA, Zhang Y, Maulik G, Makrigiorgos GM.
    Cancer Res; 2000 Jul 15; 60(14):3732-7. PubMed ID: 10919642
    [Abstract] [Full Text] [Related]

  • 16. Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors.
    Favis R, Huang J, Gerry NP, Culliford A, Paty P, Soussi T, Barany F.
    Hum Mutat; 2004 Jul 15; 24(1):63-75. PubMed ID: 15221790
    [Abstract] [Full Text] [Related]

  • 17. A separation-free assay for the detection of mutations: combination of homogeneous time-resolved fluorescence and minisequencing.
    Lopez-Crapez E, Bazin H, Chevalier J, Trinquet E, Grenier J, Mathis G.
    Hum Mutat; 2005 May 15; 25(5):468-75. PubMed ID: 15832307
    [Abstract] [Full Text] [Related]

  • 18. Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumors.
    Pfister C, Flaman JM, Martin C, Grise P, Frebourg T.
    J Urol; 1999 Jun 15; 161(6):1973-5. PubMed ID: 10332483
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Arrayed primer extension reaction for genotyping on oligonucleotide microarray.
    Pullat J, Metspalu A.
    Methods Mol Biol; 2008 Jun 15; 444():161-7. PubMed ID: 18425479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.